SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

AccelFoods, founded in 2013 and based in New York, is a private equity firm that specializes in investing in high-growth consumer goods, healthcare, retail, and agribusiness companies throughout the United States. The firm partners with driven founders to provide access to industry expertise and infrastructure, facilitating the development of innovative products and effective go-to-market strategies. By connecting emerging companies with essential resources, AccelFoods aims to foster the creation of enduring brands within the food and beverage ecosystem.

Founded in 2001, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.

Collaborative V is an early-stage venture capital fund managed by Collaborative Fund, which was founded in New York in 2010. The fund focuses on investing in technology and media within creative fields, emphasizing two key themes: the growing significance of values in consumer and employment choices, and the transition from a hyper-consumption economy to one based on collaborative consumption. These themes highlight opportunities for new technologies, products, and services that can reshape business practices and enhance everyday life. Collaborative V seeks to be a primary source of capital and strategic support for creative entrepreneurs aiming to make a positive impact in the world. Its investors include notable figures from various industries, underscoring the fund's commitment to fostering innovation and creativity.

Techstars Central LLC, founded in 2006 and based in Boulder, Colorado, operates as a startup accelerator and venture capital firm focused on supporting early-stage technology-oriented companies. It specializes in a mentorship-driven accelerator program, selecting ten startups each summer to participate in a three-month incubation period, offering funding of $120,000 in exchange for equity. Techstars invests primarily in sectors such as fintech, artificial intelligence, blockchain, augmented reality, and IoT, while avoiding investments in medical devices, healthcare technology, and local service-oriented businesses. In addition to its primary accelerator, Techstars has various specialized programs, including those focused on music, retail, mobility, and social impact, with global reach extending to regions such as Africa, Asia, and Latin America. The firm prefers taking minority stakes, typically between six and ten percent, without seeking board representation or investor rights. Techstars has built a robust network of entrepreneurs, mentors, and corporate partners to foster innovation and growth within its portfolio, which includes over 1,000 companies with a significant collective market capitalization.

AVAC Ltd. is a Canadian venture capital firm based in Calgary, Alberta, established in 1997. It specializes in both direct investments and fund-of-funds, focusing on early-stage opportunities primarily in value-added agribusiness, information and communications technology, and life sciences. The firm typically invests up to $0.5 million in pre-commercial, growth, and early-stage companies, with a preference for those located in the Alberta region. AVAC also manages the Accelerate Fund, an angel co-investment fund, and has been involved in over 115 direct investments and four national venture capital funds, contributing more than $118 million to its portfolio. Its investment strategy emphasizes active participation in the management and governance of portfolio companies, and it may also provide grants to public research and not-for-profit organizations in the agrivalue sector. Through its Ag Tech brand, Verdex Capital, AVAC supports management of investments in agricultural technology, contributing to the growth of innovative business ventures.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization established in 1982 that focuses on fostering the development and adoption of new technologies in the region. For over 30 years, it has served as a key provider of seed-stage capital, investing more than $170 million in over 1,750 regional technology companies, many of which have achieved industry leadership. In addition to financial support, Ben Franklin promotes university and industry partnerships that facilitate the commercialization of scientific discoveries. The organization is dedicated to strengthening the entrepreneurial ecosystem in Southeastern Pennsylvania, thereby creating jobs and enhancing the technology community.

Khosla Ventures is a venture capital firm established in 2004 by Vinod Khosla, a co-founder of Sun Microsystems. Based in Menlo Park, California, the firm manages over $5 billion and primarily invests in early-stage technology companies throughout the United States. Khosla Ventures provides capital, strategic advice, and venture assistance to entrepreneurs focused on breakthrough innovations across various sectors, including consumer technology, enterprise solutions, health, education, agriculture, and sustainable energy. The firm has a particular interest in high-risk, high-reward opportunities, often acting as a sole investor in "science or innovation experiments." Investment sizes typically range from $100,000 to over $20 million, allowing Khosla Ventures to support both traditional ventures and unconventional projects.

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, managing approximately $5 billion in assets. The firm specializes in a range of investment strategies, including private equity, venture capital, and public equity, targeting companies across the healthcare spectrum—from startups to large multinational corporations. OrbiMed invests in various sectors within the healthcare industry, including pharmaceuticals, biotechnology, life sciences, medical devices, and health IT. The firm typically invests between $3 million and $150 million, often seeking majority stakes in its portfolio companies. With a global investment approach, OrbiMed operates from offices in New York, San Francisco, Mumbai, Herzliya, Shanghai, West Kowloon, and Luxembourg, focusing on opportunities in North America, Europe, Asia, and Israel. Its investment strategies are underpinned by fundamental analysis, encompassing investments in public equity, fixed income, and alternative markets.

DSG Consumer Partners is a venture capital firm established in 2013, headquartered in Mauritius, with a focus on investing in consumer businesses across India and Southeast Asia. The firm primarily targets minority equity positions in unlisted companies, although it may pursue control deals when aligned with capable management teams. DSG Consumer Partners is flexible in providing growth capital and enabling liquidity for founders and shareholders through secondary transactions. The founders have a long-term investment approach, typically spanning six to ten years, and have a history of supporting notable brands since 2004, including Sula Wines, Cleartrip, and Redmart. The firm concentrates on consumer-facing sectors, leveraging its expertise to foster the growth of emerging brands in the region.